Here is a report on recent news and commentary related to the Federal Circuit and its cases. Today we highlight:
- an article arguing President Trump’s new replacement tariffs “almost certainly violate the law”;
- an article discussing how the Federal Circuit rejected “Tesla Inc.’s constitutional challenge to a Trump administration rule that makes it harder to contest the validity of patents at the U.S. Patent and Trademark Office”;
- a blog post addressing a recent Federal Circuit decision holding that “genetically engineered cultured host cells containing recombinant nucleic acid molecules are not directed to a natural phenomenon, and therefore are patent-eligible subject matter”; and
- an article reporting how the Federal Circuit recently “held unlawful the U.S. International Trade Commission’s practice of automatically treating as confidential the questionnaire responses it receives in injury investigations.”
